Recent Discovery at Froome Mine Expands Along Strike and Down-Dip; Drilling at Depth Shows Potential to Extend Mine Life: 7.7 gpt gold over 20.4 m & 23.5 gpt gold over 3.7 m (true widths) TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) is pleased to announce new drill results from its Froome Mine, part of the Fox Complex in Timmins, Ontario (Figure 1). Based on our confidence in the geological potential, four drills are now active at Froome West, targeting further expansion of these excellent results. Why These Drill Results Are Important to Our Investors 1. Si...
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings Clinical utility data for Nodify Lung® tests to be presented at North American Conference on Lung Cancer (NACLC) highlighting potential for earlier diagnosis of lung cancer Development data for a new ultra-sensitive ESR1 assay for breast cancer treatment resistance monitoring to be presented at San Antonio Breast Cancer Symposium (SABCS) LOUISVILLE, Ky., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces several poster presentations on lung cancer diagn...
Archrock Publishes its 2024 Annual Sustainability Report HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) (“Archrock” or the “Company”) today announced the publication of its , providing an update on the Company’s sustainability initiatives and performance. The report is based on 2024 data and also includes certain achievements made year-to-date in 2025, underscoring the Company’s culture of continuous improvement. 2024 Sustainability Report Highlights Exceeded safety goals for Total Recordable Incident Rate and Preventable Vehicle Incident Rate.Administered over 4...
A director at Archrock Inc sold 40,740 shares at 25.099USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Q3 2025 Operational & Financial Results and Progress Report on Key Developments to Double Production by 2030 TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) today announced its third quarter (Q3) and year-to-date (9M) results for the period ended September 30, 2025, and reported on its plan to double production by 2030, lower costs, and extend mine life across all operations. Management believes these initiatives provide an achievable path toward our goal of 250,000 to 300,000 GEOs Consolidated Annual Production by 2030. McEwen is advancing the following projec...
McEwen Q3 2025 Results Conference Call TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen”, "MUX" or the "Company”) invites you to join our conference call following the release of our Q3 2025 financial results. The call will take place on Thursday, November 6, 2025 at 11:00 AM EST. Management will discuss our financial results and project developments and follow with a question-and-answer session. Participants can ask questions directly over the phone during the webcast. Thursday, November 6, 2025 at 11:00 AM ESTToll Free North America:(888) 210-3454Toll Dia...
Biodesix Announces Third Quarter 2025 Results and Highlights Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024; Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 2024; Raised FY2025 Total Revenue Guidance to $84-86 million; Conference Call and Webcast Today at 4:30 p.m. ET LOUISVILLE, Colo., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the third quarter ended September 30, 2025. “We delivered a strong third quarter with revenue growing 20% to $...
McEwen to Acquire 31% Strategic Interest in Paragon Geochemical, Leader of PhotonAssay™ Technology for the Mining Sector TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or “MUX”) is pleased to announce that it has signed agreements to acquire an approximately 31% equity interest in Britannia Mining Solutions Inc., on a fully diluted basis. Britannia operates under the name Paragon Geochemical Laboratories Inc., a provider of advanced analytical services to the mining industry (collectively referred to as “Paragon”). Paragon is recognized for its deployment...
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher Scientific LOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. ...
McEwen Inc. Refiles the Technical Report for Fox Complex TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) announces that, as a result of a review by staff of the Ontario Securities Commission (“OSC”), we are issuing the following news release regarding our disclosure on the Fox Complex. The Company has amended and refiled its Technical Report titled “NI 43-101 Technical Report on the Mineral Resources Estimate of the Fox Complex, Ontario, Canada”, originally filed on April 4, 2025. The OSC review was conducted as part of its continuous di...
Archrock Reports Third Quarter 2025 Results and Raises 2025 Financial Guidance HOUSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today reported results for the third quarter 2025. Third Quarter 2025 and Recent Highlights Revenue for the third quarter of 2025 was $382.4 million compared to $292.2 million in the third quarter of 2024.Net income for the third quarter of 2025 was $71.2 million and EPS was $0.40, compared to $37.5 million and $0.22, respectively, in the third quarter of 2024.Adjusted net income (a non-GAAP measure defined be...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.